131 related articles for article (PubMed ID: 12707114)
1. Noninactivating tandem pore domain potassium channels as attractive targets for general anesthetics.
Johansson JS
Anesth Analg; 2003 May; 96(5):1248-1250. PubMed ID: 12707114
[No Abstract] [Full Text] [Related]
2. Molecular modeling of a tandem two pore domain potassium channel reveals a putative binding site for general anesthetics.
Bertaccini EJ; Dickinson R; Trudell JR; Franks NP
ACS Chem Neurosci; 2014 Dec; 5(12):1246-52. PubMed ID: 25340635
[TBL] [Abstract][Full Text] [Related]
3. 2P domain K+ channels: novel pharmacological targets for volatile general anesthetics.
Patel AJ; Honore E
Adv Exp Med Biol; 2003; 536():9-23. PubMed ID: 14635644
[No Abstract] [Full Text] [Related]
4. Voltage-gated ion channels.
Nau C
Handb Exp Pharmacol; 2008; (182):85-92. PubMed ID: 18175087
[TBL] [Abstract][Full Text] [Related]
5. Patents related to therapeutic activation of K(ATP) and K(2P) potassium channels for neuroprotection: ischemic/hypoxic/anoxic injury and general anesthetics.
Judge SI; Smith PJ
Expert Opin Ther Pat; 2009 Apr; 19(4):433-60. PubMed ID: 19441925
[TBL] [Abstract][Full Text] [Related]
6. Physiology and pharmacology of two-pore domain potassium channels.
Kim D
Curr Pharm Des; 2005; 11(21):2717-36. PubMed ID: 16101451
[TBL] [Abstract][Full Text] [Related]
7. The neuronal background K2P channels: focus on TREK1.
Honoré E
Nat Rev Neurosci; 2007 Apr; 8(4):251-61. PubMed ID: 17375039
[TBL] [Abstract][Full Text] [Related]
8. The TREK K2P channels and their role in general anaesthesia and neuroprotection.
Franks NP; Honoré E
Trends Pharmacol Sci; 2004 Nov; 25(11):601-8. PubMed ID: 15491783
[TBL] [Abstract][Full Text] [Related]
9. Potent activation of the human tandem pore domain K channel TRESK with clinical concentrations of volatile anesthetics.
Liu C; Au JD; Zou HL; Cotten JF; Yost CS
Anesth Analg; 2004 Dec; 99(6):1715-1722. PubMed ID: 15562060
[TBL] [Abstract][Full Text] [Related]
10. International Union of Pharmacology. LV. Nomenclature and molecular relationships of two-P potassium channels.
Goldstein SA; Bayliss DA; Kim D; Lesage F; Plant LD; Rajan S
Pharmacol Rev; 2005 Dec; 57(4):527-40. PubMed ID: 16382106
[No Abstract] [Full Text] [Related]
11. TREK-1, a K+ channel involved in neuroprotection and general anesthesia.
Heurteaux C; Guy N; Laigle C; Blondeau N; Duprat F; Mazzuca M; Lang-Lazdunski L; Widmann C; Zanzouri M; Romey G; Lazdunski M
EMBO J; 2004 Jul; 23(13):2684-95. PubMed ID: 15175651
[TBL] [Abstract][Full Text] [Related]
12. Update on tandem pore (2P) domain K+ channels.
Yost CS
Curr Drug Targets; 2003 May; 4(4):347-51. PubMed ID: 12699355
[TBL] [Abstract][Full Text] [Related]
13. Emerging roles for two-pore-domain potassium channels and their potential therapeutic impact.
Bayliss DA; Barrett PQ
Trends Pharmacol Sci; 2008 Nov; 29(11):566-75. PubMed ID: 18823665
[TBL] [Abstract][Full Text] [Related]
14. Properties and modulation of mammalian 2P domain K+ channels.
Patel AJ; Honoré E
Trends Neurosci; 2001 Jun; 24(6):339-46. PubMed ID: 11356506
[TBL] [Abstract][Full Text] [Related]
15. Two-pore domain potassium channels: new sites of local anesthetic action and toxicity.
Kindler CH; Yost CS
Reg Anesth Pain Med; 2005; 30(3):260-74. PubMed ID: 15898030
[TBL] [Abstract][Full Text] [Related]
16. Differential effects of general anesthetics on G protein-coupled inwardly rectifying and other potassium channels.
Yamakura T; Lewohl JM; Harris RA
Anesthesiology; 2001 Jul; 95(1):144-53. PubMed ID: 11465552
[TBL] [Abstract][Full Text] [Related]
17. Regulatory Effect of General Anesthetics on Activity of Potassium Channels.
Li Y; Xu J; Xu Y; Zhao XY; Liu Y; Wang J; Wang GM; Lv YT; Tang QY; Zhang Z
Neurosci Bull; 2018 Oct; 34(5):887-900. PubMed ID: 29948841
[TBL] [Abstract][Full Text] [Related]
18. [Cardiac two-pore-domain potassium channels (K2P): Physiology, pharmacology, and therapeutic potential].
Schmidt C; Wiedmann F; Schweizer PA; Katus HA; Thomas D
Dtsch Med Wochenschr; 2012 Aug; 137(33):1654-8. PubMed ID: 22875694
[TBL] [Abstract][Full Text] [Related]
19. Propofol postsynaptically suppresses stellate neuron excitability in the entorhinal cortex by influencing the HCN and TREK-2 channels.
Li X; Pan K; Zhu D; Li Y; Tao G
Neurosci Lett; 2016 Apr; 619():54-9. PubMed ID: 26971702
[TBL] [Abstract][Full Text] [Related]
20. Evidence for TREK-like tandem-pore domain channels in intrapulmonary chemoreceptor chemotransduction.
Bina RW; Hempleman SC
Respir Physiol Neurobiol; 2007 May; 156(2):120-31. PubMed ID: 17071144
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
